Authors' response to letter to editor-silencing GATA3: DNAzymes enter the therapeutic landscape of ulcerative colitis. Atreya R, Neurath MF. Inflamm Bowel Dis 2026 May 11:izag077. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Atreya R, Neurath MF. Authors' response to letter to editor-silencing GATA3: DNAzymes enter the therapeutic landscape of ulcerative colitis. Inflamm Bowel Dis 2026 May 11:izag077. doi: 10.1093.
PMID: 42113907